SynopsisDealShare, once valued at $1.7 billion, is in advanced talks to be acquired by online pharmacy Truemeds in a share-swap deal. The transaction would value DealShare at a little over its cash balance, while Truemeds would issue shares to its investors. The deal would mark a steep valuation reset for DealShare.Ecommerce startup DealShare, which was valued at $1.7 billion at its peak in 2022, is now in advanced talks to be acquired by online pharmacy Truemeds in a share-swap transaction that would value it at a little over its $90 million cash balance, people aware of the matter told ET.Under the proposed structure, Truemeds will issue shares to DealShare’s investors at a valuation of about $600 million, while DealShare is expected to be valued at itsNow Playing
DealShare, once valued at $1.7 billion, may sell to Truemeds for little over $90 million - The Economic Times
DealShare, once valued at $1.7 billion, is in advanced talks to be acquired by online pharmacy Truemeds in a share-swap deal. The transaction would value DealShare at a little over its cash balance, while Truemeds would issue shares to its investors. The deal would mark a steep valuation reset for DealShare.
127 words~1 min read
